Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 14:5:610-617.
doi: 10.1016/j.trci.2019.09.006. eCollection 2019.

Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images

Affiliations

Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images

Sayed Mehran Sharafi et al. Alzheimers Dement (N Y). .

Abstract

Introduction: This study investigates the relationship between retinal image features and β-amyloid (Aβ) burden in the brain with the aim of developing a noninvasive method to predict the deposition of Aβ in the brain of patients with Alzheimer's disease.

Methods: Retinal images from 20 cognitively impaired and 26 cognitively unimpaired cases were acquired (3 images per subject) using a hyperspectral retinal camera. The cerebral amyloid status was determined from binary reads by a panel of 3 expert raters on 18F-florbetaben positron-emission tomography (PET) studies. Image features from the hyperspectral retinal images were calculated, including vessels tortuosity and diameter and spatial-spectral texture measures in different retinal anatomical regions.

Results: Retinal venules of amyloid-positive subjects (Aβ+) showed a higher mean tortuosity compared with the amyloid-negative (Aβ-) subjects. Arteriolar diameter of Aβ+ subjects was found to be higher than the Aβ- subjects in a zone adjacent to the optical nerve head. Furthermore, a significant difference between texture measures built over retinal arterioles and their adjacent regions were observed in Aβ+ subjects when compared with the Aβ-. A classifier was trained to automatically discriminate subjects combining the extracted features. The classifier could discern Aβ+ subjects from Aβ- subjects with an accuracy of 85%.

Discussion: Significant differences in texture measures were observed in the spectral range 450 to 550 nm which is known as the spectral region known to be affected by scattering from amyloid aggregates in the retina. This study suggests that the inclusion of metrics related to the retinal vasculature and tissue-related textures extracted from vessels and surrounding regions could improve the discrimination performance of the cerebral amyloid status.

Keywords: Alzheimer; Beta amyloid; Image processing; Machine learning; Multispectral fundus imaging; Retina.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic of the metabolic hyperspectral retinal camera used for acquiring the images.
Fig. 2
Fig. 2
(A) Tortuosity measurement steps of a sample vessel segment. (B) Different zones of retina: zone A (region from 0 to 0.5 ONH diameters away from the ONH margin), zone B (region from 0.5 to 1 ONH diameters away from the ONH margin), and zone C (region from 0.5 to 2 ONH diameters away from the ONH margin).
Fig. 3
Fig. 3
Difference between β-amyloid-positive and β-amyloid-negative data sets corresponding to features F1 (A) to F8 (H)—Data points are shown as normalized values.
Fig. 4
Fig. 4
(A) SVM classification loss using principal components 1 to 8 inclusively; (B) comparison of classification losses when using different types of features.

References

    1. Masters C.L., Bateman R., Blennow K., Rowe C.C., Sperling R.A., Cummings J.L. Alzheimer's disease. Nat Rev Dis Primers. 2015;1:15056. - PubMed
    1. Jack C.R., Jr., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14:535–562. - PMC - PubMed
    1. Ceccaldi M., Jonveaux T., Verger A., Krolak-Salmon P., Houzard C., Godefroy O. Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: a naturalistic study. Alzheimers Dement. 2018;14:293–305. - PubMed
    1. Grundman M., Johnson K.A., Lu M., Siderowf A., Dell'Agnello G., Arora A.K. Effect of amyloid imaging on the diagnosis and management of patients with cognitive decline: impact of appropriate use criteria. Dement Geriatr Cogn Disord. 2016;41:80–92. - PMC - PubMed
    1. Rabinovici G.D., Gatsonis C., Apgar C., Gareen I.F., Hanna L., Hendrix J. Impact of amyloid PET on patient management: early results from the ideas study. Alzheimers Dement. 2017;13:P1474.